Evidence mapPaperPMID 40248256Full record

ArticleFrontiers in cardiovascular medicine2025

Neutrophil to high-density lipoprotein cholesterol ratio predicts left ventricular remodeling and MACE after PCI in patients with acute ST-segment elevation myocardial infarction.

Jianlin Chen, Anbang Liu, Dan Zhang, Tingting Meng, Xinhe Zhang, Weihong Xu, Yan Zheng, Guohai Su

Abstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jianlin Chen *School of Clinical Medicine, Shandong Second Medical University, Weifang, China.
Anbang Liu *Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, China.
Dan ZhangDepartment of Cardiovascular Medicine, Jinan Central Hospital, Jinan, Shandong, China.
Tingting MengShandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, China.
Xinhe ZhangShandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, China.
Weihong XuShandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, China.
Yan ZhengDepartment of Cardiovascular Medicine, Jinan Central Hospital, Jinan, Shandong, China.
Guohai SuSchool of Clinical Medicine, Shandong Second Medical University, Weifang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The neutrophil to high-density lipoprotein cholesterol ratio (NHR) has been proposed as a potential marker for predicting cardiovascular events. However, its prognostic role following percutaneous coronary intervention (PCI) in patients with acute ST-segment elevation myocardial infarction (STEMI) remains unclear. This study aimed to evaluate the predictive value of NHR for left ventricular remodeling (LVR) and long-term outcomes in STEMI patients post-PCI. Methods: This retrospective study included 299 STEMI patients who underwent PCI and were followed for 24 months post-procedure. Echocardiography was performed upon admission and at 6 months post-myocardial infarction (MI). LVR was defined as an increase in left ventricular diastolic volume (LVEDV) of at least 20% from baseline. Based on their VR status, patients were divided into LVR ( Results: Among the 299 STEMI patients enrolled in the study, LVR was observed in 81 patients after 24 months of follow-up. The LVR group had significantly higher NHR levels compared to the non-LVR group (8.19 ± 1.95 vs. 6.23 ± 1.91, Conclusions: NHR is an independent predictor of LVR and MACE after PCI in STEMI patients. Monitoring NHR may aid in identifying high-risk patients early, facilitating individualized treatment.

Indexed as

biomarkermajor adverse cardiovascular eventsmyocardial infarctionneutrophil to high-density lipoprotein cholesterol ratioventricular remodeling

Identifiers

PMID40248256
PMCPMC12003286

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.